Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype

被引:186
作者
Levite, M [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
关键词
T helper cells 1 and 2;
D O I
10.1073/pnas.95.21.12544
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Searching for nervous system candidates that could directly induce T cell cytokine secretion, I tested four neuropeptides (NPs): somatostatin, calcitonin gene-related peptide, neuropeptide Y, and substance P. Comparing neuropeptide-driven versus classical antigen driven cytokine secretion from T helper cells Th0, Th1, and Th2 autoimmune-related T cell populations, I show that the tested NPs, in the absence of any additional factors, directly induce a marked secretion of cytokines [interleukin 2 (IL-2), interferon-gamma, IL-4, and IL-10) from T cells. Furthermore, NPs drive distinct Th1 and Th2 populations to a "forbidden" cytokine secretion: secretion of Th2 cytokines from a Th1 T cell line and vice versa. Such a phenomenon cannot be induced by classical antigenic stimulation. My study suggests that the nervous system, through NPs interacting with their specific T cell-expressed receptors, can lead to the secretion of both typical and atypical cytokines, to the breakdown of the commitment to a distinct Th phenotype, and a potentially altered function and destiny of T cells in vitro.
引用
收藏
页码:12544 / 12549
页数:6
相关论文
共 33 条
[1]   Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis [J].
Aharoni, R ;
Teitelbaum, D ;
Sela, M ;
Arnon, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10821-10826
[2]  
Benveniste EN, 1995, HUMAN CYTOKINES THEI, P195
[3]   Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection [J].
Bocher, WO ;
HerzogHauff, S ;
Herr, W ;
Heermann, K ;
Gerken, G ;
zumBuschenfelde, KHM ;
Lohr, HF .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01) :52-58
[4]  
CALVO CF, 1992, J IMMUNOL, V148, P3498
[5]   Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches [J].
Constant, SL ;
Bottomly, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :297-322
[6]   NUMBER OF INTERLEUKIN-4-SECRETING AND INTERFERON-GAMMA-SECRETING HUMAN T-CELLS REACTIVE WITH TETANUS TOXOID AND THE MYCOBACTERIAL ANTIGEN PPD OR PHYTOHEMAGGLUTININ - DISTINCT RESPONSE PROFILES DEPENDING ON THE TYPE OF ANTIGEN USED FOR ACTIVATION [J].
ELGHAZALI, GEB ;
PAULIE, S ;
ANDERSSON, G ;
HANSSON, Y ;
HOLMQUIST, G ;
SUN, JB ;
OLSSON, T ;
EKRE, HP ;
TROYEBLOMBERG, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (11) :2740-2745
[7]   VACCINATION AGAINST AUTOIMMUNE MOUSE DIABETES WITH A T-CELL EPITOPE OF THE HUMAN 65-KDA HEAT-SHOCK PROTEIN [J].
ELIAS, D ;
RESHEF, T ;
BIRK, OS ;
VANDERZEE, R ;
WALKER, MD ;
COHEN, IR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) :3088-3091
[8]  
JOHNSTON JA, 1994, J IMMUNOL, V153, P1762
[9]  
Khachatryan A, 1997, J IMMUNOL, V158, P1409
[10]  
KHORUTS A, 1995, J IMMUNOL, V155, P5011